logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Eutropics Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 23.1


Trademarks = 1

Forward Citations = 76

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Michael H Cardone (12 out of 13 patents)

silverMedal Andrew Kolodziej (4 out of 15 patents)

bronzeMedal David James Richard (4 out of 33 patents)

4.  Xiang Y Yu (2 out of 35 patents)

5.  Anthony Letai (1 out of 15 patents)

6.  Elisha J Dettman (1 out of 1 patent)

7.  William Edward Pierceall (1 out of 4 patents)

8.  Michael Cardone (1 out of 1 patent)

9.  Andrew F Kolodziej (0 patent)


13 patents:

1. 12742764 - METHODS FOR PREDICTING CANCER DRUG RESPONSIVENESS (2026-09-22),
2. 11656230 - Method for predicting cancer sensitivity (2023-05-23),
3. 10793915 - Context dependent diagnostics test for guiding cancer treatment (2020-10-06),
4. 10765673 - Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives (2020-09-08),
5. 10732182 - Method for predicting cancer sensitivity (2020-08-04),
6. 10640803 - Methods for determining chemosensitivity and chemotoxicity (2020-05-05),
7. 10413549 - Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivatives (2019-09-17),
8. 9360473 - Assay system to identify therapeutic agents (2016-06-07),
9. 9351971 - Substituted 2,2'-biphenazines for treating diseases (2016-05-31),
10. 9345700 - Compositions and methods useful for treating diseases (2016-05-24),
11. 9051305 - Compositions and methods useful for treating diseases (2015-06-09),
12. 8987271 - 2,2'-biphenazine compounds and methods useful for treating disease (2015-03-24),
13. 8168755 - Antibodies specific to heterodimers of Bcl-2 family and uses thereof (2012-05-01),
Company Overview
Eutropics Pharmaceuticals, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapeutics for the treatment of various diseases. The company focuses on leveraging advanced drug discovery techniques and proprietary technologies to address unmet medical needs. Eutropics is dedicated to advancing its research in areas such as molecular biology and pharmacology, aiming to enhance patient outcomes through targeted therapies and novel treatment modalities.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#193 in Cambridge, MA

#1,443 in Massachusetts

#23,863 in US

#45,104 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Eutropics Pharmaceuticals, Inc.

Forward Citations = 76

8 inventors:

goldMedal Michael H Cardone (12 out of 13 patents)

silverMedal Andrew Kolodziej (4 out of 15 patents)

bronzeMedal David James Richard (4 out of 33 patents)

4.  Xiang Y Yu (2 out of 35 patents)

5.  Anthony Letai (1 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eutropics Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/eutropics-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…